glp-1 for sleep apnea May Amplify Survival Benefits in Type 2 Diabetes GLP-1 Medications Show Promise as
Description
10.2337/diabetes.49.5.741 117 SunH.ZhangA.GongY.SunW.YanB.LeiS.et al (2022)
Gallbladder disorders were reported in 2.6% of patients on semaglutide versus 1.2% on placebo more than double the rate
Icon presence alone doesn't confirm the underlying documentation
If you take oral semaglutide (Wegovy Pill), strict fasting and water restrictions apply you must take it on an empty stomach with no more than 4 ounces of water, then wait 30 minutes before eating
The generic GLP-1 approval from the US Food and Drug Administration (FDA) is for Teva Pharmaceuticals version of Novo Nordisks injectable Saxenda (liraglutide)
Research suggests that GLP-1 medications target areas of the brain involved with sensations of thirst as well as hunger, thus muting thirst cues
